Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read more on GILD stock here.
Daniel Ives You can reverse the age of cells all the way down to zero in just a few weeks. So you can actually take a ...
Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including hemogl ...
Poster outlines clinical benefit with acceptable safety profile across 9 tested dosing regimensAccelerated step-up dosing and higher dosing frequency is feasible and results in increased exposure Six ...
Information on admissions, scholarships, new courses, research studies and other events at schools and colleges ...
Samsung Electronics Co., Ltd. announced the launch of Galaxy Z TriFold, further expanding Samsung’s leadership in new form ...
The Oakland Press on MSN
Oakland County community calendar Dec. 7 and beyond
• Oakland County Parks and Recreation offers free admission. General park entry fees and vehicle permits have been eliminated ...
Bezuclastinib achieves clear clinical benefit across all symptom domains including significant improvements on 11 individual ...
The Greater Johnstown High School boys basketball team opened its season with a convincing victory over Chestnut Ridge Wednesday at Doc Stofko Gymnasium. The Trojans took a positive step as they ...
Samsung Electronics Company Limited today announced the launch of Galaxy Z TriFold, further expanding Samsung’s leadership in ...
She was only 12 when she was diagnosed with familial adenomatous polyposis (FAP), an inherited condition that causes hundreds ...
Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback